TRUE Private Wealth Advisors Invests $4.39 Million in SPDR S&P Biotech (XBI)

TRUE Private Wealth Advisors acquired a new stake in SPDR S&P Biotech (NYSEARCA:XBI) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 50,744 shares of the exchange traded fund’s stock, valued at approximately $4,392,000. SPDR S&P Biotech comprises about 1.0% of TRUE Private Wealth Advisors’ holdings, making the stock its 20th largest position.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Ballentine Partners LLC acquired a new stake in shares of SPDR S&P Biotech in the second quarter valued at approximately $121,000. National Planning Corp acquired a new stake in shares of SPDR S&P Biotech in the second quarter valued at approximately $211,000. Boston Advisors LLC acquired a new stake in shares of SPDR S&P Biotech in the second quarter valued at approximately $213,000. Northstar Asset Management LLC acquired a new stake in shares of SPDR S&P Biotech in the third quarter valued at approximately $217,000. Finally, Institute for Wealth Management LLC. acquired a new stake in shares of SPDR S&P Biotech in the second quarter valued at approximately $218,000.

COPYRIGHT VIOLATION WARNING: This article was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this article on another site, it was illegally stolen and reposted in violation of US and international copyright law. The original version of this article can be read at https://www.com-unik.info/2017/10/31/true-private-wealth-advisors-invests-4-39-million-in-spdr-sp-biotech-xbi.html.

SPDR S&P Biotech (XBI) traded down 0.49% during mid-day trading on Tuesday, hitting $83.60. The stock had a trading volume of 1,643,139 shares. The firm’s 50-day moving average price is $85.36 and its 200-day moving average price is $77.68. SPDR S&P Biotech has a 1-year low of $53.15 and a 1-year high of $88.98.

SPDR S&P Biotech Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Institutional Ownership by Quarter for SPDR S&P Biotech (NYSEARCA:XBI)

What are top analysts saying about SPDR S&P Biotech? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for SPDR S&P Biotech and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit